moyamoya disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients between 20 and 65 years of age at the time of consent 2.Those who were diagnosed as moyamoya disease according to the guidelines of MMD proposed by the Research Committee on spontaneous occlusion of the circle of Willis 3.Those patients who gave informed consent based on own will or the will of a guardian
Exclusion criteria
Exclusion criteria: 1.Quasimoyamoya syndrome with conditions such as Down syndrome and neurofibromatosis 2.Stroke with neurological deficit 3.Psychological or neurological disorders which affect the neuropsychological test performance 4.Vision or hearing impairment or motor disability which affects the neuropsychological test performance 5.Contraindications for MRI (cardiac pacemaker, inner ear implant, claustrophobia, etc) 6.Revascularization surgery before the study 7.Conditions in which the principal investigator considers not suitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of correct answers in the PASAT score before and after the neurocognitive training and the magnitude of change in the scores | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Pre- and post-neurocognitive training neuropsychological test results (trail making test part A and B, digit span test, tapping span test, standard verbal paired-associate learning test scores)and the magnitude of change 2.Pre- and post-training morphological and functional imaging results and the magnitude of change 3.Correlation between the morphological and functional imaging results and the neuropsychological performance (the magnitude of change in each score before and after training) | — |
Countries
Japan
Contacts
Hokkaido University Graduate School of Biomedical Science and Engineering